Primary sclerosing cholangitis
00:00 / 00:00
Videos
Notes
Primary sclerosing cholangitis
Gastrointestinal system
Gastrointestinal system
Gastrointestinal system
Gastrointestinal system
Gastrointestinal system
Assessments
Primary sclerosing cholangitis
Flashcards
0 / 9 complete
USMLE® Step 1 questions
0 / 3 complete
High Yield Notes
13 pages
Flashcards
Primary sclerosing cholangitis
of complete
Questions
USMLE® Step 1 style questions USMLE
of complete
Which of the following complications is associated with this patient’s disease process?
Memory Anchors and Partner Content
External References
First Aid
2022
2021
2020
2019
2018
2017
2016
Cholangiocarcinomas
sclerosing cholangitis p. 404
Gallbladder cancer
sclerosing cholangitis and p. 404
IgM antibodies p. 103
in sclerosing cholangitis p. 404
Inflammatory bowel disease (IBD) p. 391
sclerosing cholangitis and p. 404
p-ANCA
sclerosing cholangitis and p. 404
Primary sclerosing cholangitis p. 404
ulcerative colitis p. 391
Sclerosing cholangitis p. 402, 404
ulcerative colitis association p. 391
External Links
Transcript
Content Reviewers
Contributors
The name “primary sclerosing cholangitis” or PSC, is actually pretty straightforward, primary refers to it not being known to have been caused by anything else, in other words it isn’t secondary to something else.
Sclerosing means hardening of the tissue and cholangitis is inflammation of the bile ducts.
So with PSC we have this fibrosis and inflammation of both the intra- and extra-hepatic ducts, so inside and outside the liver.
As these cells around the bile ducts become inflamed, die, and harden due to fibrosis, you get this like tightening of the ducts in some areas where there’s been serious fibrosis, and then dilation in other areas that aren’t as affected, and this leads to the classic PSC finding of this sort of “beaded” appearance of the bile ducts.
These areas of fibrosis in the bile ducts can also be seen on histology, and looks a bit like an onion skin since you’ve got these concentric rings of fibrosis around the bile duct, so sometimes it’s referred to as “onion-skin fibrosis”.
Again, with PSC, we don’t really know what causes it right? One clue though is that it’s been known to be associated with ulcerative colitis which is an autoimmune disease and crohn’s disease which is immune-system related; knowing that, PSC’s thought to possibly be an autoimmune disorder itself involving the immune system’s T cells attacking and destroying bile duct epithelial cells.
Why they might start doing this, though, is not very well known, and likely happens in people with certain genetic predispositions when they’re exposed to some specific stimuli in their environment.
Certain genetic factors have been linked to developing PSC; studies have shown that patients with PSC tend to have in common specific human leukocyte antigens, or HLAs.
HLAs are these specific markers on cells that tell your body whether these cells are your own cells or someone else’s cells, and sometimes, for reasons that are usually not well known, the body’s immune system might think that certain HLAs or cell surface markers are foreign even when they’re your own, leading to an autoimmune disorder.
Specific HLA’s that have been common among people with PSC are HLA-B8, HLA-DR3, and HLA-DRw52a.
Another piece of supporting evidence for the autoimmune theory is that most patients with PSC have elevated IgM antibody levels in the serum, as well as an antibody called p-ANCA.
Summary
Primary sclerosing cholangitis (PSC) is a disease of the bile ducts that causes inflammation and obliterative fibrosis of bile ducts inside and/or outside of the liver. This results in scarring of the biliary tree, which impedes the flow of bile to the intestines and can ultimately lead to cirrhosis of the liver, liver failure, and liver cancer. Symptoms of PSC can include fatigue, itching, jaundice, abdominal pain, and weight loss. If left untreated, PSC can lead to liver failure. Definitive treatment is liver transplant, but ursodeoxycholic acid (UDCA help to slow disease progression and alleviate symptoms.
Sources
- "Robbins Basic Pathology" Elsevier (2017)
- "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
- "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
- "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
- "Primary Sclerosing Cholangitis" New England Journal of Medicine (2016)
- "The dynamic biliary epithelia: Molecules, pathways, and disease" Journal of Hepatology (2013)
- "Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis" Annals of Hepatology (2014)
For Institutions
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
